Velakast Tablets are a powerful combination medication designed for the treatment of chronic hepatitis C virus (HCV) infection. Each tablet contains
Sofosbuvir at a concentration of
400 mg and
Velpatasvir at
100 mg, working synergistically to inhibit the replication of the virus.
**Indications:** Velakast is indicated for the treatment of adults with chronic hepatitis C genotype 1, 2, 3, 4, 5, or 6, and is effective in patients with or without cirrhosis.
**Dosage and Administration:** The recommended dosage is one tablet taken orally once daily, with or without food. It is essential to follow your healthcare provider's instructions regarding the duration of treatment.
**Active Ingredients:**
- Sofosbuvir: 400 mg
- Velpatasvir: 100 mg
**Additional Ingredients:** Each tablet may also contain inactive ingredients such as microcrystalline cellulose, magnesium stearate, and others.
**Warnings:** Consult your healthcare provider before use if you have a history of liver disease other than hepatitis C, or if you are pregnant or breastfeeding. Regular monitoring of liver function is recommended during treatment.
**Storage:** Store at room temperature, away from moisture and heat. Keep out of reach of children.
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
You can add a rating once you purchase the product through the My Orders page
